Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanan Goldberg

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Annals of Surgical Oncology|February 8, 2021
The Suggested Importance of PBRM1 Mutation in Predicting Postoperative Recurrence of Localized Clear Cell Renal Cell CarcinomaHanan Goldberg
Urology|December 3, 2019
AUTHOR REPLYHanan Goldberg
The Journal of Urology|June 15, 2021
Editorial CommentHanan Goldberg
The Journal of Urology|July 7, 2023
Editorial CommentHanan Goldberg
The Journal of Urology|September 13, 2022
Editorial CommentHanan Goldberg
Translational Andrology and Urology|June 10, 2024
Modifying and personalizing prostate cancer screeningAlexandra Stone, Hanan Goldberg
The Urologic Clinics of North America|November 20, 2025
From Screening to Decision: The Current Landscape of Localized Prostate Cancer ManagementHanan Goldberg, Gennady Bratslavsky
Current Opinion in Supportive and Palliative Care|June 8, 2017
Novel imaging in advanced prostate cancerHanan Goldberg, Robert J Hamilton
Cancer Management and Research|November 22, 2022
Role of Rucaparib in the Treatment of Prostate Cancer: Clinical Perspectives and ConsiderationsMaximillian S Wu, Hanan Goldberg
Current Opinion in Urology|May 14, 2013
Defining high-risk prostate cancerHanan Goldberg, Jack Baniel, Ofer Yossepowitch
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Annals of Surgical Oncology|February 8, 2021
The Suggested Importance of PBRM1 Mutation in Predicting Postoperative Recurrence of Localized Clear Cell Renal Cell CarcinomaHanan Goldberg
Urology|December 3, 2019
AUTHOR REPLYHanan Goldberg
The Journal of Urology|June 15, 2021
Editorial CommentHanan Goldberg
The Journal of Urology|July 7, 2023
Editorial CommentHanan Goldberg
The Journal of Urology|September 13, 2022
Editorial CommentHanan Goldberg
Translational Andrology and Urology|June 10, 2024
Modifying and personalizing prostate cancer screeningAlexandra Stone, Hanan Goldberg
The Urologic Clinics of North America|November 20, 2025
From Screening to Decision: The Current Landscape of Localized Prostate Cancer ManagementHanan Goldberg, Gennady Bratslavsky
Current Opinion in Supportive and Palliative Care|June 8, 2017
Novel imaging in advanced prostate cancerHanan Goldberg, Robert J Hamilton
Cancer Management and Research|November 22, 2022
Role of Rucaparib in the Treatment of Prostate Cancer: Clinical Perspectives and ConsiderationsMaximillian S Wu, Hanan Goldberg
Current Opinion in Urology|May 14, 2013
Defining high-risk prostate cancerHanan Goldberg, Jack Baniel, Ofer Yossepowitch
Pageof 13